[go: up one dir, main page]

PT93959A - Processo para a preparacao de derivados de sacarina uteis como inibidores proteoliticos de enzima - Google Patents

Processo para a preparacao de derivados de sacarina uteis como inibidores proteoliticos de enzima

Info

Publication number
PT93959A
PT93959A PT93959A PT9395990A PT93959A PT 93959 A PT93959 A PT 93959A PT 93959 A PT93959 A PT 93959A PT 9395990 A PT9395990 A PT 9395990A PT 93959 A PT93959 A PT 93959A
Authority
PT
Portugal
Prior art keywords
enzyme inhibitors
uacal
sacarine
derivatives
preparation
Prior art date
Application number
PT93959A
Other languages
English (en)
Other versions
PT93959B (pt
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of PT93959A publication Critical patent/PT93959A/pt
Publication of PT93959B publication Critical patent/PT93959B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT93959A 1989-05-04 1990-05-04 Processo para a preparacao de derivados de sacarina uteis como inibidores proteoliticos de enzima PT93959B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34712589A 1989-05-04 1989-05-04
US34712689A 1989-05-04 1989-05-04

Publications (2)

Publication Number Publication Date
PT93959A true PT93959A (pt) 1991-01-08
PT93959B PT93959B (pt) 1996-11-29

Family

ID=26995139

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93959A PT93959B (pt) 1989-05-04 1990-05-04 Processo para a preparacao de derivados de sacarina uteis como inibidores proteoliticos de enzima

Country Status (17)

Country Link
EP (1) EP0471756B1 (pt)
JP (1) JPH04507095A (pt)
KR (1) KR0183397B1 (pt)
AT (1) ATE159720T1 (pt)
AU (1) AU637614B2 (pt)
DE (1) DE69031656T2 (pt)
DK (1) DK0471756T3 (pt)
ES (1) ES2110414T3 (pt)
FI (1) FI103111B1 (pt)
GR (1) GR1000965B (pt)
IL (1) IL94278A (pt)
MY (1) MY106202A (pt)
NO (1) NO300808B1 (pt)
NZ (1) NZ233521A (pt)
PT (1) PT93959B (pt)
SG (1) SG48298A1 (pt)
WO (1) WO1990013549A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008217A (en) * 1995-12-20 1999-12-28 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US6204261B1 (en) 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5874424A (en) * 1995-12-20 1999-02-23 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5380737A (en) * 1989-05-04 1995-01-10 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5512589A (en) * 1990-11-01 1996-04-30 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5250696A (en) * 1990-11-01 1993-10-05 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylate
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
AU656027B2 (en) * 1991-11-15 1995-01-19 Sanofi Saccharin derivative proteolytic enzime inhibitors
AU668694B2 (en) * 1991-12-19 1996-05-16 Sanofi-Synthelabo Saccharin derivative proteolytic enzyme inhibitors
US5378720A (en) * 1991-12-19 1995-01-03 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5187173A (en) * 1991-12-27 1993-02-16 Sterling Winthrop Inc. 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5296496A (en) * 1991-12-27 1994-03-22 Sterling Winthrop Inc. 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW226016B (pt) * 1991-12-30 1994-07-01 Sterling Winthrop Inc
DE4413951C1 (de) * 1994-04-21 1995-08-03 Cpc Maizena Gmbh Verfahren zur Herstellung einer Würzsoße
US6420522B1 (en) 1995-06-05 2002-07-16 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5684195A (en) * 1994-07-14 1997-11-04 G. D. Searle & Co. Method of preparing sulfmonamides from sulfones
DE4427996A1 (de) * 1994-08-08 1996-02-15 Basf Ag Verfahren zur Herstellung von Saccharincarbonsäuren und -carbonsäureestern
US5494925A (en) * 1994-12-02 1996-02-27 Sterling Winthrop Inc. 2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
US5843904A (en) * 1995-12-20 1998-12-01 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1βconverting enzyme
EP2203412A4 (en) * 2007-10-16 2012-01-11 Univ Northeastern MONOACYLGLYCEROLLIPASE HEMMER FOR MODULATION OF CANNABINOIDACTIVITY

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1302858B (pt) * 1962-09-21 1972-05-04
JPS47419B1 (pt) * 1969-12-22 1972-01-07
US4195023A (en) * 1975-08-20 1980-03-25 Merck & Co., Inc. 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin
DE2800019A1 (de) * 1978-01-02 1979-07-12 Dynamit Nobel Ag N-halobenzyl-saccharine, ihre herstellung und verwendung
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4350752A (en) * 1980-12-29 1982-09-21 Eastman Kodak Company Photographic elements and film units containing imidomethyl blocked photographic reagents
US4410618A (en) * 1982-06-11 1983-10-18 Eastman Kodak Company Blocked photographic reagents
CS241932B1 (cs) * 1984-05-25 1986-04-17 Jiri Svoboda Způsob výroby substituovaných benzisothiazolin- -3-on-l,1-dioxidů
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
JPH07200419A (ja) * 1993-12-28 1995-08-04 Nec Corp バスインタフェース装置

Also Published As

Publication number Publication date
NO914217L (no) 1991-10-28
PT93959B (pt) 1996-11-29
KR0183397B1 (ko) 1999-05-01
EP0471756A4 (en) 1992-04-08
DE69031656T2 (de) 1998-04-09
MY106202A (en) 1995-03-31
KR920701203A (ko) 1992-08-11
EP0471756A1 (en) 1992-02-26
NO914217D0 (no) 1991-10-28
ES2110414T3 (es) 1998-02-16
SG48298A1 (en) 1998-04-17
JPH04507095A (ja) 1992-12-10
IL94278A (en) 1995-03-30
DE69031656D1 (de) 1997-12-04
EP0471756B1 (en) 1997-10-29
FI915093A0 (fi) 1991-10-29
GR1000965B (el) 1993-03-16
WO1990013549A1 (en) 1990-11-15
AU637614B2 (en) 1993-06-03
FI103111B (fi) 1999-04-30
AU5664990A (en) 1990-11-29
DK0471756T3 (da) 1998-05-18
IL94278A0 (en) 1991-03-10
NO300808B1 (no) 1997-07-28
FI103111B1 (fi) 1999-04-30
ATE159720T1 (de) 1997-11-15
NZ233521A (en) 1992-05-26
GR900100326A (en) 1991-10-10

Similar Documents

Publication Publication Date Title
PT93959A (pt) Processo para a preparacao de derivados de sacarina uteis como inibidores proteoliticos de enzima
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
FI942423A0 (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
PT83873B (pt) Processo de preparacao de medicamentos contendo hexadecilfosfocolina
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
PT90246A (pt) Processo para a preparacao de inibidores da protease do hiv, nomeadamente amidas de aminoacidos, uteis para o tratamento da sida
FI925787A (fi) Proteolytiska enzymers sackarinderivatinhibitorer
PT89502A (pt) Processo para a preparacao de derivados de 2-(2-hidroxi-3-fenoxi-metilo e de composicoes farmaceuticas que os contem
MX23889A (es) Derivados de cromanos y tiocromanos, procedimiento para su preparacion y composicion farmaceutica.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ES539777A0 (es) Procedimiento para la produccion de indolofenantridinas
BR8803768A (pt) Composicao odorante,processo para producao de compostos e uso dos ditos compostos
ES2020925B3 (es) Nuevas sales cristalinas de ariloxipropanolaminas, procedimiento para su preparacion y utilizacion de las mismas.
DK585984D0 (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
BR9709264A (pt) Processo para produzir e composto
PT83253B (pt) Processo para a preparacao de p-acilaminobenzamidas
DK0408713T3 (da) Phenylsulfonderivater
MX9304608A (es) Nuevas (n-metanosulfonil)-quinolilmetoxifenil-cicoalquilacetamidas sustituidas por isobutilo, procedimiento para su preparacion y medicamentos que las contienen.
ES2037688T3 (es) Procedimiento para la realizacion de oxidaciones enzimaticas.
FI103114B1 (fi) Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi
FR2604704B1 (fr) Derives de 4-phenylthiazole, procede de preparation et utilisation en therapeutique
MX163201B (es) Proceso para la preparacion de 2-metil-1,2-hexanodioles opticamente activos
NO20012328D0 (no) Fluorerte 3,4-dihydrokinolinderivater anvendt som NOS- inhibitorer
UY24851A1 (es) Derivados de ácidos n-acil-alfa-aminados

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960902

PC3A Transfer or assignment

Free format text: 980513 SANOFI FR

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000331